XLAB d.o.o

OUTFRONT Media Wins Gold & Bronze Lion in Cannes

Retrieved on: 
Tuesday, July 11, 2023

OUTFRONT XLabs is OUTFRONT's interdisciplinary, creative innovation group focused on the intersection of human-centered design and outdoor media.

Key Points: 
  • OUTFRONT XLabs is OUTFRONT's interdisciplinary, creative innovation group focused on the intersection of human-centered design and outdoor media.
  • Said Shackelford, "To win Gold and Bronze at Cannes Lions is such an amazing moment for the entire XLabs team.
  • OUTFRONT XLabs and OUTFRONT STUDIOS combine to provide OUTFRONT with formidable creative firepower within the industry and beyond.
  • The OUTFRONT STUDIOS and XLabs teams are the recipient of over 175 combined creative awards, including the prestigious Gold and Bronze Cannes Lion.

PharmaLedger Association Launches Digital Trust Ecosystem in Healthcare

Retrieved on: 
Monday, March 13, 2023

BASEL, Switzerland, March 13, 2023 (GLOBE NEWSWIRE) -- The PharmaLedger Association™ (PLA), a not-for-profit based in Switzerland, announces the endorsement of its 3-year strategic plan to implement and promote a Digital Trust Ecosystem in healthcare (DTE-H) at its Annual General Meeting held in Lucerne, Switzerland on 1 March 2023.

Key Points: 
  • BASEL, Switzerland, March 13, 2023 (GLOBE NEWSWIRE) -- The PharmaLedger Association™ (PLA), a not-for-profit based in Switzerland, announces the endorsement of its 3-year strategic plan to implement and promote a Digital Trust Ecosystem in healthcare (DTE-H) at its Annual General Meeting held in Lucerne, Switzerland on 1 March 2023.
  • PLA has confirmed its mandate as a pre-competition umbrella organization delivering common and interoperable digital solutions in the areas of Product Trust, Decentralized Clinical Trials, and Supply Chain Traceability.
  • In Q2 2023, the Association will continue with the development of new products in its innovation xLab, including of a product digital twin, decentralized identities, and verifiable credentials to facilitate visibility, security, traceability, and trust in all areas of healthcare.
  • With PLA we have the right vehicle, resources, and roadmap to take patients to a better place in healthcare,” Daniel Fritz, Executive Director, PharmaLedger Association.

JAPAN HOUSE Los Angeles Presents “Designing With Disaster: Stories From Seven Regenerative Cities”

Retrieved on: 
Thursday, January 5, 2023

LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles , a Japanese cultural destination in the heart of Hollywood, announces its upcoming exhibition “Designing with Disaster: Stories from Seven Regenerative Cities” on display from January 27 – April 2, 2023.

Key Points: 
  • LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles , a Japanese cultural destination in the heart of Hollywood, announces its upcoming exhibition “Designing with Disaster: Stories from Seven Regenerative Cities” on display from January 27 – April 2, 2023.
  • The exhibition also features illuminated Regenerative City Wells (“Wells”) with an immersive physical, video, and audio experience envisioning seven hypothetical regenerative cities.
  • In conjunction with the upcoming exhibition, the UCLA Terasaki Center for Japanese Studies and JAPAN HOUSE Los Angeles will co-host the Global Japan Forum 2023: Designing with Disaster to be held on January 28, 2023 from 2 p.m. – 5 p.m. at JAPAN HOUSE Los Angeles.
  • Walk-ins are invited and the gallery is open daily from
    For more information, visit the JAPAN HOUSE Los Angeles website and social channels: Facebook , Instagram , Twitter , YouTube and LinkedIn .

OUTFRONT MEDIA ENHANCES OUTFRONT PRIME WITH NEW SOCIAL OUT-OF-HOME OFFERINGS, HARNESSING THE POWER OF SOCIAL + PREMIUM OOH ASSETS ACROSS TOP TIER MARKETS

Retrieved on: 
Wednesday, November 30, 2022

NEW YORK, Nov. 30, 2022 /PRNewswire/ -- OUTFRONT Media (NYSE:OUT), one of the largest out-of-home media (OOH) companies in the U.S., today announced that it has enhanced OUTFRONT PRIME with new social out-of-home (sOOH) capabilities. OUTFRONT PRIME expands the company's reach to brands looking to harness this powerful combination by marrying social media and influencer activations with OOH campaigns on its most premium assets.

Key Points: 
  • OUTFRONT PRIME expands the company's reach to brands looking to harness this powerful combination by marrying social media and influencer activations with OOH campaigns on its most premium assets.
  • OUTFRONT has begun rolling out new branding across its PRIME locations, featuring the "#outfrontprime" hashtag in order to emphasize this capability.
  • OUTFRONT PRIME marks the evolution of this "social out-of-home" strategy, taking the powerful results noted above, and bringing it to the company's largest, most iconic inventory.
  • Connecting IRL to URL, OUTFRONT PRIME locations serve as a social media primer, delivering measurable traction and consumer engagement.

iXensor announces partnership with Innova Medical Group at 2022 MEDICA

Retrieved on: 
Monday, November 14, 2022

DSSELDORF, Germany, Nov. 13, 2022 /PRNewswire/ -- iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group.

Key Points: 
  • DSSELDORF, Germany, Nov. 13, 2022 /PRNewswire/ -- iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group.
  • At MEDICA, Innova Medical Group presents the high-end PHRONESIA Smart Ovulation Test, the first "Powered by iXensor Technology" product, into its range of PHRONESIA self-tests portfolio.
  • Expedited by the COVID-19 pandemic, some medical testing has shifted from central labs to point-of-care and now to consumers' homes as self-testing.
  • Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions.

iXensor announces partnership with Innova Medical Group at 2022 MEDICA

Retrieved on: 
Monday, November 14, 2022

DSSELDORF, Germany, Nov. 14, 2022 /PRNewswire/ -- iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group.

Key Points: 
  • DSSELDORF, Germany, Nov. 14, 2022 /PRNewswire/ -- iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group.
  • At MEDICA, Innova Medical Group presents the high-end PHRONESIA Smart Ovulation Test, the first "Powered by iXensor Technology" product, into its range of PHRONESIA self-tests portfolio.
  • Expedited by the COVID-19 pandemic, some medical testing has shifted from central labs to point-of-care and now to consumers' homes as self-testing.
  • Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions.

JAPAN HOUSE Los Angeles Announces “MA in Japanese Film” Webinar With Ryūsuke Hamaguchi, Director of Academy Award-Shortlisted “Drive My Car”

Retrieved on: 
Thursday, January 20, 2022

LOS ANGELES, Jan. 20, 2022 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles , a Japanese cultural destination in the heart of Hollywood, announces MA in Japanese Film: In Conversation with Film Director Rysuke Hamaguchi, the final webinar in its Rethinking of MA Webinar Series.

Key Points: 
  • LOS ANGELES, Jan. 20, 2022 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles , a Japanese cultural destination in the heart of Hollywood, announces MA in Japanese Film: In Conversation with Film Director Rysuke Hamaguchi, the final webinar in its Rethinking of MA Webinar Series.
  • Through the four-part Rethinking of MA series, JAPAN HOUSE explores the diverse ways MA is applied everywhere from art, architecture, and food.
  • So, its fitting that ma can be observed most directly in traditions of architecture and interior design, said Yuko Kaifu, president, JAPAN HOUSE Los Angeles.
  • For more information, visit the JAPAN HOUSE Los Angeles website and social channels: Facebook , Instagram , Twitter , YouTube and LinkedIn .

MEDX Xelerator Commences $1 Million, Interventional Oncology Technology Challenge Chaired by Professor Stephen B. Solomon

Retrieved on: 
Wednesday, December 15, 2021

OR YEHUDA, Israel, Dec. 15, 2021 /PRNewswire/ --MEDX Xelerator is scouting worldwide for disruptive products, ideas and unmet needs in interventional oncology and has commenced its first annual million dollar challenge in this pursuit.

Key Points: 
  • OR YEHUDA, Israel, Dec. 15, 2021 /PRNewswire/ --MEDX Xelerator is scouting worldwide for disruptive products, ideas and unmet needs in interventional oncology and has commenced its first annual million dollar challenge in this pursuit.
  • Winners will be selected by an esteemed panel of judges chaired by Professor Stephen B. Solomon, Chief Interventional Radiologist at the Cancer Institute of Memorial Sloan Kettering Cancer Center.
  • Current partners and collaborators include: Boston Scientific, MEDX Venture Group, Sheba Medical Center, Consensus Business Group (CBG) and West Pharmaceuticals.
  • Though headquartered in Israel, the incubator is open to innovation coming from entrepreneurs, universities and hospitals worldwide.